122 related articles for article (PubMed ID: 10575369)
1. 1-Imidazolylcarbonyloxy-substituted tetrahydroquinolines and pyridines: synthesis and evaluation of P450 TxA2 inhibition.
Hartmann RW; Frotscher M
Arch Pharm (Weinheim); 1999 Oct; 332(10):358-62. PubMed ID: 10575369
[TBL] [Abstract][Full Text] [Related]
2. 1-imidazolyl(alkyl)-substituted di- and tetrahydroquinolines and analogues: syntheses and evaluation of dual inhibitors of thromboxane A(2) synthase and aromatase.
Jacobs C; Frotscher M; Dannhardt G; Hartmann RW
J Med Chem; 2000 May; 43(9):1841-51. PubMed ID: 10794700
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
Watts IS; Wharton KA; White BP; Lumley P
Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
[TBL] [Abstract][Full Text] [Related]
4. Tröger's base. An alternate synthesis and a structural analog with thromboxane A2 synthetase inhibitory activity.
Johnson RA; Gorman RR; Wnuk RJ; Crittenden NJ; Aiken JW
J Med Chem; 1993 Oct; 36(21):3202-6. PubMed ID: 8230108
[TBL] [Abstract][Full Text] [Related]
5. Imidazol-1-yl and pyridin-3-yl derivatives of 4-phenyl-1,4-dihydropyridines combining Ca2+ antagonism and thromboxane A2 synthase inhibition.
Cozzi P; Carganico G; Fusar D; Grossoni M; Menichincheri M; Pinciroli V; Tonani R; Vaghi F; Salvati P
J Med Chem; 1993 Oct; 36(20):2964-72. PubMed ID: 8411014
[TBL] [Abstract][Full Text] [Related]
6. ZD9583, an orally effective thromboxane A2 synthase inhibitor and receptor antagonist with a sustained duration of action in rat and dog.
Brownlie RP; Brownrigg NJ; Butcher HM; Garcia R; Jessup R; Lee VJ; Tunstall S; Wayne MG
J Pharm Pharmacol; 1997 Feb; 49(2):187-94. PubMed ID: 9055193
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 3. Pyridinylalkyl-substituted 8-[(arylsulfonyl)amino]octanoic acids.
Main AJ; Bhagwat SS; Boswell C; Goldstein R; Gude C; Cohen DS; Furness P; Lee W; Louzan M
J Med Chem; 1992 Nov; 35(23):4366-72. PubMed ID: 1447737
[TBL] [Abstract][Full Text] [Related]
8. [Research and development of ozagrel, a highly selective inhibitor of TXA2 synthase].
Nakazawa M; Iizuka K; Ujiie A; Hiraku S; Ohki S
Yakugaku Zasshi; 1994 Dec; 114(12):911-33. PubMed ID: 7869235
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 17.
Wächter GA; Hartmann RW; Sergejew T; Grün GL; Ledergerber D
J Med Chem; 1996 Feb; 39(4):834-41. PubMed ID: 8632407
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 2. Synthesis and biological activity of 8-(benzenesulfonamido)-7-(3-pyridinyl)octaonic acid and related compounds.
Main AJ; Goldstein R; Cohen DS; Furness P; Lee W
J Med Chem; 1992 Nov; 35(23):4362-5. PubMed ID: 1447736
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane synthetase inhibitors: design and synthesis of a novel series of omega-pyridylalkenoic acids.
Terao S; Kato K; Ohkawa S; Terashita Z; Nishikawa K
Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():315-7. PubMed ID: 2936112
[No Abstract] [Full Text] [Related]
12. Thromboxane A2 synthase inhibitors. 5-(3-Pyridylmethyl)benzofuran-2-carboxylic acids.
Johnson RA; Nidy EG; Aiken JW; Crittenden NJ; Gorman RR
J Med Chem; 1986 Aug; 29(8):1461-8. PubMed ID: 3735314
[TBL] [Abstract][Full Text] [Related]
13. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
Cozzi P; Giordani A; Menichincheri M; Pillan A; Pinciroli V; Rossi A; Tonani R; Volpi D; Tamburin M; Ferrario R
J Med Chem; 1994 Oct; 37(21):3588-604. PubMed ID: 7932586
[TBL] [Abstract][Full Text] [Related]
14. Ridogrel: a selective inhibitor of the cytochrome P450-dependent thromboxane synthesis.
Vanden Bossche H; Willemsens G; Bellens D; Janssen PA
Biochem Pharmacol; 1992 Feb; 43(4):739-44. PubMed ID: 1540227
[TBL] [Abstract][Full Text] [Related]
15. [(1H-imidazol-1-yl)methyl]- and [(3-pyridinyl)methyl]pyrroles as thromboxane synthetase inhibitors.
Martinez GR; Walker KA; Hirschfeld DR; Maloney PJ; Yang DS; Rosenkranz RP
J Med Chem; 1989 Apr; 32(4):890-7. PubMed ID: 2704033
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of thromboxane synthesis and platelet aggregation by pyridine and its derivatives.
Tai HH; Lee N; Tai CL
Adv Prostaglandin Thromboxane Res; 1980; 6():447-52. PubMed ID: 7189951
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 1. (+/-)-(3-pyridinylbicycloheptyl)alkanoic acids.
Bhagwat SS; Gude C; Cohen DS; Lee W; Furness P; Clarke FH
J Med Chem; 1991 Jun; 34(6):1790-7. PubMed ID: 1829485
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 5. Synthesis and evaluation of enantiomers of 8-[[(4-chlorophenyl)sulfonyl]amino]-4-(3-pyridinylalkyl)octanoic acid.
Bhagwat SS; Gude C; Cohen DS; Dotson R; Mathis J; Lee W; Furness P
J Med Chem; 1993 Jan; 36(2):205-10. PubMed ID: 8423593
[TBL] [Abstract][Full Text] [Related]
19. CV-4151--a potent, selective thromboxane A2 synthetase inhibitor.
Terashita Z; Imura Y; Tanabe M; Kawazoe K; Nishikawa K; Kato K; Terao S
Thromb Res; 1986 Jan; 41(2):223-37. PubMed ID: 3083523
[TBL] [Abstract][Full Text] [Related]
20. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. VI. Indazole derivatives.
Yamaguchi M; Maruyama N; Koga T; Kamei K; Akima M; Kuroki T; Hamana M; Ohi N
Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):332-4. PubMed ID: 7728936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
